Rate Notice: 5.9% general rate increase Jan 1, 2026 — Learn More
    UNIS logo
    DR.

    Dr. Reddys Laboratories Inc.

    Dr. Reddy’s Laboratories Inc. is a global pharmaceutical leader accelerating access to affordable, innovative medicines across 76 countries, with strong R&D and manufacturing capabilities.

    Company Overview

    Dr. Reddy’s Laboratories Inc. operates in the pharmaceutical industry, focusing on the development, manufacturing, and commercialization of prescription drugs and active pharmaceutical ingredients. The company serves over 800 million patients globally, with a robust presence in the US, Europe, and emerging markets. Their portfolio spans oncology, hematology, immunology, cardiovascular, gastrointestinal, and dermatology therapeutic areas.

    Key Metrics

    1,200

    Import Shipments

    12

    Distribution Centers

    4.1B

    Annual Revenue

    1984

    Founded

    Company Profile

    Key Milestones

    Important company milestones and achievements.

    Markets Served

    Geographic markets and customer segments served.

    Ownership Structure

    Corporate ownership and organizational structure.

    Sales Channels

    Distribution networks and sales approaches.

    Recent Developments

    Dr. Reddy’s Laboratories Inc. is actively expanding its specialty drug pipeline, biosimilars portfolio, and consumer health business, while investing in digital transformation and global supply chain resilience.

    Strategic Expansion

    Launch of new specialty generics and biosimilars in oncology and immunology

    Market Expansion

    Strategic efforts to expand market presence and reach new customer segments.

    Technology Adoption

    Implementation of advanced technologies to improve service delivery and customer experience.

    Business Information

    Dr. Reddy’s Laboratories Inc. is committed to providing affordable and innovative medicines worldwide, with a mission to improve global health outcomes. The company produces over 190 medications and 60 APIs, supporting both branded and generic drug markets. Their operations include advanced R&D, manufacturing facilities certified to international standards, and a growing consumer health business. Dr. Reddy’s leverages strategic acquisitions and global partnerships to expand its reach and product offerings.

    Headquarters

    Hyderabad, India (Global HQ); East Brunswick, New Jersey, USA (US HQ)

    Founded

    1984

    Stock Symbol

    RDY